Candidate factors include tumor-secreted molecules previously implicated in MDCS formation, such as GM-CSF, VEGF, IL-1β, IL-6, and prostaglandin E2 [24,27], but other tumor-derived factors may be involved. This evidence concerns the gene IL6 and neoplasm.